Ipsogen, Sysmex Reach Distribution Deal | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – French molecular diagnostics firm Ipsogen today announced a distribution deal with Sysmex covering Japan.

Under the deal, Sysmex, based in Kobe, Japan, will distribute certain Ipsogen blood cancer products in Japan. Sysmex also will be responsible for the regulatory submission of Ipsogen products directed at the diagnosis and monitoring of BCR-ABL and JAK2 to Japanese health authorities. Sysmex has the exclusive rights to sell these products in Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.